chrX-85107782-A-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001367857.2(SATL1):āc.1187T>Cā(p.Met396Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000273 in 1,098,221 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 3 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001367857.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SATL1 | NM_001367857.2 | c.1187T>C | p.Met396Thr | missense_variant | 3/8 | ENST00000644105.2 | NP_001354786.1 | |
SATL1 | NM_001367858.2 | c.1187T>C | p.Met396Thr | missense_variant | 7/12 | NP_001354787.1 | ||
SATL1 | NM_001012980.2 | c.1187T>C | p.Met396Thr | missense_variant | 1/5 | NP_001012998.2 | ||
SATL1 | XM_047442081.1 | c.1187T>C | p.Met396Thr | missense_variant | 2/7 | XP_047298037.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SATL1 | ENST00000644105.2 | c.1187T>C | p.Met396Thr | missense_variant | 3/8 | NM_001367857.2 | ENSP00000494345.1 |
Frequencies
GnomAD3 genomes Cov.: 24
GnomAD4 exome AF: 0.00000273 AC: 3AN: 1098221Hom.: 0 Cov.: 32 AF XY: 0.00000825 AC XY: 3AN XY: 363575
GnomAD4 genome Cov.: 24
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 29, 2024 | The c.1187T>C (p.M396T) alteration is located in exon 1 (coding exon 1) of the SATL1 gene. This alteration results from a T to C substitution at nucleotide position 1187, causing the methionine (M) at amino acid position 396 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.